*0011421131
*008061127s2006    xx#           000 0 nob
*019  $bk
*08230$a614.4
*100  $aKjeken, Rune$uInovio Biomedical Corporation, Sorrento, San Diego, CA, USA ; kjeken@inovio.com$_136936500
*245  $aDNA - fremtidens vaksine?
*300  $aS. 2964-2968 : ill.
*5208 $aInneholder sammendrag
*650  $aDNA$2norart$_12703000
*650  $aVaksiner$2norart$_31795200
*650  $aforebygging$2norart$_58353200
*650  $agener$2norart$_92678300
*650  $asykdommer$9nor$2norart$_128646300
*700  $aBogen, Bjarne;$uImmunologisk institutt, Rikshospitalet-Radiumhospitalet ; Universitetet i Oslo$_150885400
*700  $aMathiesen, Iacob$uInovio AS, Oslo$_154082400
*773  $tTidsskrift for Den norske legeforening$gÅrg. 126, nr 22 (2006)$x0029-2001$w(NO-LaBS)552783(tnr)
*999  $z600397787$anorart:600397787
^